Search research articles
Contact Us
Filters
Showing results (41-50 of 81) with videos related to
Page
of 9
Sort By:
Neuroepidemiology
|
January 1, 1993
Validity of the International Headache Society criteria for migraine. GRIM. Groupe de Recherche Interdisciplinaire sur la Migraine
P Michel, J F Dartigues, P Henry, et al.
Revue Neurologique
|
July 28, 2020
French validation of the Brief International Cognitive Assessment for Multiple Sclerosis
N Maubeuge, M S A Deloire, B Brochet, et al.
Journal of the Neurological Sciences
|
October 6, 2000
In vivo evaluation of remyelination in rat brain by magnetization transfer imaging
M S Deloire-Grassin, B Brochet, B Quesson, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
December 14, 2019
Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC
T Berger, B Brochet, L Brambilla, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 12, 2006
How to detect cognitive dysfunction at early stages of multiple sclerosis?
M S A Deloire, M C Bonnet, E Salort, et al.
AJNR. American Journal of Neuroradiology
|
May 12, 2006
MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium
V Dousset, B Brochet, M S A Deloire, et al.
Neuroimage
|
May 3, 2006
Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE
B Brochet, M S A Deloire, T Touil, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 26, 2008
Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study
B Brochet, M S A Deloire, M Bonnet, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 9, 2002
International consensus statement on the use of disease-modifying agents in multiple sclerosis
M S Freedman, L D Blumhardt, B Brochet, et al.
Journal of the Neurological Sciences
|
May 28, 2020
Effect of cognitive rehabilitation on neuropsychological and semiecological testing and on daily cognitive functioning in multiple sclerosis: The REACTIV randomized controlled study
D Lamargue, I Koubiyr, M Deloire, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 81) with videos related to
Sort By:
Page
of 9
Neuroepidemiology
|
January 1, 1993
Validity of the International Headache Society criteria for migraine. GRIM. Groupe de Recherche Interdisciplinaire sur la Migraine
P Michel, J F Dartigues, P Henry, et al.
Revue Neurologique
|
July 28, 2020
French validation of the Brief International Cognitive Assessment for Multiple Sclerosis
N Maubeuge, M S A Deloire, B Brochet, et al.
Journal of the Neurological Sciences
|
October 6, 2000
In vivo evaluation of remyelination in rat brain by magnetization transfer imaging
M S Deloire-Grassin, B Brochet, B Quesson, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
December 14, 2019
Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC
T Berger, B Brochet, L Brambilla, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 12, 2006
How to detect cognitive dysfunction at early stages of multiple sclerosis?
M S A Deloire, M C Bonnet, E Salort, et al.
AJNR. American Journal of Neuroradiology
|
May 12, 2006
MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium
V Dousset, B Brochet, M S A Deloire, et al.
Neuroimage
|
May 3, 2006
Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE
B Brochet, M S A Deloire, T Touil, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 26, 2008
Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study
B Brochet, M S A Deloire, M Bonnet, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 9, 2002
International consensus statement on the use of disease-modifying agents in multiple sclerosis
M S Freedman, L D Blumhardt, B Brochet, et al.
Journal of the Neurological Sciences
|
May 28, 2020
Effect of cognitive rehabilitation on neuropsychological and semiecological testing and on daily cognitive functioning in multiple sclerosis: The REACTIV randomized controlled study
D Lamargue, I Koubiyr, M Deloire, et al.
Page
of 9